X-137030712-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_054021.2(GPR101):c.963G>T(p.Lys321Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000306 in 1,209,139 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_054021.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPR101 | NM_054021.2 | c.963G>T | p.Lys321Asn | missense_variant | 2/2 | ENST00000651716.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPR101 | ENST00000651716.2 | c.963G>T | p.Lys321Asn | missense_variant | 2/2 | NM_054021.2 | P1 | ||
ENST00000693626.2 | n.394-29813C>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000360 AC: 4AN: 111106Hom.: 0 Cov.: 22 AF XY: 0.0000601 AC XY: 2AN XY: 33300
GnomAD3 exomes AF: 0.0000984 AC: 18AN: 182990Hom.: 0 AF XY: 0.000104 AC XY: 7AN XY: 67458
GnomAD4 exome AF: 0.0000301 AC: 33AN: 1098033Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 12AN XY: 363399
GnomAD4 genome AF: 0.0000360 AC: 4AN: 111106Hom.: 0 Cov.: 22 AF XY: 0.0000601 AC XY: 2AN XY: 33300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.963G>T (p.K321N) alteration is located in exon 1 (coding exon 1) of the GPR101 gene. This alteration results from a G to T substitution at nucleotide position 963, causing the lysine (K) at amino acid position 321 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at